These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35152540)

  • 1. Newly-developed vitiligo following COVID-19 mRNA vaccine.
    Uğurer E; Sivaz O; Kıvanç Altunay İ
    J Cosmet Dermatol; 2022 Apr; 21(4):1350-1351. PubMed ID: 35152540
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo following the COVID-19 Vaccination and Infection.
    Green M; Feschuk A; Kashetsky N; Maibach HI
    Skinmed; 2023; 21(3):213-216. PubMed ID: 37634112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Facial Vitiligo After SARS-CoV-2 Vaccination].
    Flores-Terry MÁ; García-Arpa M; Santiago-Sánchez Mateo JL; Romero Aguilera G
    Actas Dermosifiliogr; 2022; 113(7):721. PubMed ID: 35221340
    [No Abstract]   [Full Text] [Related]  

  • 4. A new-onset vitiligo following the inactivated COVID-19 vaccine.
    Koç Yıldırım S
    J Cosmet Dermatol; 2022 Feb; 21(2):429-430. PubMed ID: 34910371
    [No Abstract]   [Full Text] [Related]  

  • 5. Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Janbakhsh A; Afshar ZM
    J Cosmet Dermatol; 2023 Apr; 22(4):1152-1156. PubMed ID: 36762373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    Tsai TF; Ng CY
    J Dermatol; 2023 Aug; 50(8):982-989. PubMed ID: 37186102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo worsened following the second dose of mRNA SARS-CoV-2 vaccine.
    Caroppo F; Deotto ML; Tartaglia J; Belloni Fortina A
    Dermatol Ther; 2022 Jun; 35(6):e15434. PubMed ID: 35266259
    [No Abstract]   [Full Text] [Related]  

  • 8. Sudden onset of vitiligo after COVID-19 vaccine.
    Ciccarese G; Drago F; Boldrin S; Pattaro M; Parodi A
    Dermatol Ther; 2022 Jan; 35(1):e15196. PubMed ID: 34751491
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "COVID vaccine-induced lichen planus on areas previously affected by vitiligo".
    Bularca E; Monte-Serrano J; Villagrasa-Boli P; Lapeña-Casado A; de-la-Fuente S
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e423-e425. PubMed ID: 35148438
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphea and COVID-19 mRNA vaccine.
    Sookaromdee P; Wiwanitkit V
    Int J Dermatol; 2022 May; 61(5):e162. PubMed ID: 35230704
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis.
    Faissner S; Richter D; Ceylan U; Schneider-Gold C; Gold R
    J Neurol; 2022 Apr; 269(4):1774-1775. PubMed ID: 34435250
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.
    Metin Z; Celepli P
    Int J Dermatol; 2022 May; 61(5):639-641. PubMed ID: 35073411
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 14. Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
    Stellini R; Gianello R; Meloni A; Croce E; Materzanini P; Gomarasca W
    Infection; 2022 Jun; 50(3):791-793. PubMed ID: 34855188
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.
    Spiera E; Agrawal M; Ungaro RC
    Gastroenterology; 2022 Mar; 162(3):987-988. PubMed ID: 34626602
    [No Abstract]   [Full Text] [Related]  

  • 16. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.
    Durmus O; Akdogan N; Karadag O; Gokoz O
    Dermatol Ther; 2022 May; 35(5):e15363. PubMed ID: 35133700
    [No Abstract]   [Full Text] [Related]  

  • 18. Thromboembolic events following mRNA vaccines for COVID 19: a case series.
    Serrao A; Agrippino R; Brescini M; Mormile R; Chistolini A
    J Thromb Thrombolysis; 2022 May; 53(4):971-973. PubMed ID: 35118582
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.
    Koumaki D; Krueger-Krasagakis SE; Papadakis M; Katoulis AC; Gkiaouraki I; Zografaki K; Mylonakis D; Krasagakis K
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e411-e415. PubMed ID: 35075691
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Parker C; Thompson D; Panchanathan SS; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(35):1115-1120. PubMed ID: 36048728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.